Viktoriya Borisevich

4.8k total citations
76 papers, 2.2k citations indexed

About

Viktoriya Borisevich is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Viktoriya Borisevich has authored 76 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Infectious Diseases, 40 papers in Epidemiology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Viktoriya Borisevich's work include Viral Infections and Vectors (47 papers), Viral Infections and Outbreaks Research (43 papers) and Virology and Viral Diseases (28 papers). Viktoriya Borisevich is often cited by papers focused on Viral Infections and Vectors (47 papers), Viral Infections and Outbreaks Research (43 papers) and Virology and Viral Diseases (28 papers). Viktoriya Borisevich collaborates with scholars based in United States, Netherlands and Canada. Viktoriya Borisevich's co-authors include Thomas W. Geisbert, Robert W. Cross, Karla A. Fenton, Krystle N. Agans, Joan B. Geisbert, Chad E. Mire, Daniel J. Deer, Barry Rockx, Abhishek N. Prasad and Courtney Woolsey and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Viktoriya Borisevich

73 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Viktoriya Borisevich United States	28	1.7k	1.1k	298	286	140	76	2.2k
Elaine Haddock United States	31	2.2k 1.3×	728 0.7×	224 0.8×	356 1.2×	156 1.1×	62	2.6k
Olga Dolnik Germany	29	2.2k 1.3×	767 0.7×	405 1.4×	143 0.5×	259 1.9×	57	2.9k
Julie Callison United States	17	1.4k 0.8×	589 0.6×	186 0.6×	169 0.6×	114 0.8×	30	1.7k
Greg Saturday United States	22	1.4k 0.8×	399 0.4×	162 0.5×	173 0.6×	123 0.9×	62	1.8k
Kyle Rosenke United States	20	845 0.5×	516 0.5×	250 0.8×	128 0.4×	121 0.9×	57	1.4k
Rebecca Rosenke United States	21	1.3k 0.8×	378 0.4×	251 0.8×	268 0.9×	139 1.0×	47	1.8k
Lisa Oestereich Germany	22	1.3k 0.7×	405 0.4×	135 0.5×	328 1.1×	90 0.6×	47	1.5k
Amy C. Shurtleff United States	19	1.0k 0.6×	338 0.3×	229 0.8×	291 1.0×	108 0.8×	30	1.4k
Hiroko Miyamoto Japan	21	930 0.5×	683 0.6×	207 0.7×	145 0.5×	146 1.0×	54	1.4k
Wun‐Ju Shieh United States	15	1.1k 0.7×	440 0.4×	156 0.5×	461 1.6×	96 0.7×	21	1.5k

Countries citing papers authored by Viktoriya Borisevich

Since Specialization

Citations

This map shows the geographic impact of Viktoriya Borisevich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktoriya Borisevich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktoriya Borisevich more than expected).

Fields of papers citing papers by Viktoriya Borisevich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktoriya Borisevich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktoriya Borisevich. The network helps show where Viktoriya Borisevich may publish in the future.

Co-authorship network of co-authors of Viktoriya Borisevich

This figure shows the co-authorship network connecting the top 25 collaborators of Viktoriya Borisevich. A scholar is included among the top collaborators of Viktoriya Borisevich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viktoriya Borisevich. Viktoriya Borisevich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cross, Robert W., Jacquelyn Turcinovic, Abhishek N. Prasad, et al.. (2026). Oral 4′-fluorouridine rescues nonhuman primates from advanced Lassa fever. Nature. 650(8103). 961–969.

Cross, Robert W., Courtney Woolsey, Abhishek N. Prasad, et al.. (2025). Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primates. Nature Medicine. 31(4). 1303–1311. 5 indexed citations

Prasad, Abhishek N., Courtney Woolsey, Viktoriya Borisevich, et al.. (2025). Remdesivir, mAb114, REGN-EB3, and ZMapp partially rescue nonhuman primates infected with a low passage Kikwit variant of Ebola virus. Nature Communications. 16(1). 3824–3824. 1 indexed citations

Leyva-Grado, Victor H., Dominique Promeneur, Krystle N. Agans, et al.. (2024). Establishing an immune correlate of protection for Nipah virus in nonhuman primates. npj Vaccines. 9(1). 244–244.

Halfmann, Peter, Viktoriya Borisevich, Corri B. Levine, et al.. (2023). The Mucin-Like Domain of the Ebola Glycoprotein Does Not Impact Virulence or Pathogenicity in Ferrets. The Journal of Infectious Diseases. 228(Supplement_7). S587–S593.

Amaya, Moushimi, Lianying Yan, Viktoriya Borisevich, et al.. (2023). A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses. Viruses. 15(5). 1077–1077. 7 indexed citations

Cross, Robert W., Abhishek N. Prasad, Courtney Woolsey, et al.. (2023). Natural history of nonhuman primates after conjunctival exposure to Ebola virus. Scientific Reports. 13(1). 4175–4175. 10 indexed citations

Wong, Teri Ann S., Michael M. Lieberman, Jake Yalley-Ogunro, et al.. (2023). Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection. Vaccine. 42(3). 598–607. 4 indexed citations

Cross, Robert W., Courtney Woolsey, Abhishek N. Prasad, et al.. (2022). A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever. Cell Reports. 40(3). 111094–111094. 27 indexed citations

10.

Foster, Stephanie L., Courtney Woolsey, Viktoriya Borisevich, et al.. (2022). A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease. Proceedings of the National Academy of Sciences. 119(12). e2200065119–e2200065119. 38 indexed citations

11.

Ye, Xin, Lorne Palmer, Eleni Samaridou, et al.. (2022). Combination treatment of mannose and GalNAc conjugated small interfering RNA protects against lethal Marburg virus infection. Molecular Therapy. 31(1). 269–281. 13 indexed citations

12.

Royal, Joshua M., Carrie A. Simpson, Alison A. McCormick, et al.. (2021). Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle. Vaccines. 9(11). 1347–1347. 48 indexed citations

13.

Zeitlin, Larry, Robert W. Cross, Joan B. Geisbert, et al.. (2021). Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody. Proceedings of the National Academy of Sciences. 118(11). 14 indexed citations

14.

Amaya, Moushimi, Han Cheng, Viktoriya Borisevich, et al.. (2021). A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery. Antiviral Research. 193. 105084–105084. 11 indexed citations

15.

Mire, Chad E., Yee‐Peng Chan, Viktoriya Borisevich, et al.. (2019). A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection. The Journal of Infectious Diseases. 221(Supplement_4). S471–S479. 49 indexed citations

16.

León, Alberto J., Viktoriya Borisevich, Robert L. Seymour, et al.. (2018). Host gene expression profiles in ferrets infected with genetically distinct henipavirus strains. PLoS neglected tropical diseases. 12(3). e0006343–e0006343. 23 indexed citations

17.

Mire, Chad E., Joan B. Geisbert, Viktoriya Borisevich, et al.. (2017). Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody. Science Translational Medicine. 9(384). 69 indexed citations

18.

Pécheur, Eve‐Isabelle, Viktoriya Borisevich, Peter Halfmann, et al.. (2016). The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses. Journal of Virology. 90(6). 3086–3092. 127 indexed citations

19.

Satterfield, Benjamin A., Robert W. Cross, Karla A. Fenton, et al.. (2016). Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets. Journal of Virology. 90(14). 6326–6343. 40 indexed citations

20.

Hernandez, Humberto, Caleb Marceau, Julie Callison, et al.. (2015). Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All KnownEbolavirusSpecies. The Journal of Infectious Diseases. 212(suppl 2). S410–S413. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact